Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 3, 2013, Pages 636-641

  Boccalini, Sara ^a   Pellegrino, Elettra ^a   Tiscione, Emila ^a   Pesavento, Giovanna ^a   Bechini, Angela ^a   Levi, Miriam ^a   Rapi, Stefano ^b   Mercurio, Stefano ^b   Mannelli, Francesco ^c   Peruzzi, Marta ^c   Berardi, Cesare ^a   Bonanni, Paolo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Hepatitis B; Incidence; Italy; Prevalence; Sero epidemiology; Vaccination; Viral markers

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; BLOOD SAMPLING; CHILD; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SURVEILLANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HEALTH PROGRAM; HEPATITIS B; HUMAN; INCIDENCE; INFANT; ITALY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PREVENTIVE HEALTH SERVICE; SEROEPIDEMIOLOGY; SEX DIFFERENCE; TREND STUDY; VACCINATION; AGE; BLOOD; EPIDEMIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HUMANS; INCIDENCE; INFANT; ITALY; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; VACCINATION; YOUNG ADULT;

EID: 84874703149     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.23259     Document Type: Conference Paper

References (25)

1. World Health Organization (WHO). Hepatitis B. Immunization, Vaccines and Biologicals. WHO website. Available at: http://www.who.int/immunization/topics/ hepatitis-b/en. Last accessed: October 2012.
2. European Centre for Disease Prevention and Control (ECDC). Hepatitis B and C - World hepatitis day 2010. ECDC website. Available at: http://www.ecdc. europa.eu. Last accessed: October 2012.
3. World Health Organization (WHO). Hepatitis B. Immunization surveillance, assessment and monitoring. WHO website. Available at: http://www.who.int/ immunization-monitoring/diseases/hepatitis/en/index. html. Last accessed: October 2012.
4. Van Damme P, Kane M, Meheus A; Viral Hepatitis Prevention Board. Integration of hepatitis B vaccination into national immunisation programmes. BMJ 1997; 314:1033-6; PMID:9112852; http://dx.doi.org/10.1136/bmj.314.7086.1033.
5. World Health Organization/UNICEF. Global Immunization Data. Available to: http://www.who.int/immunization-monitoring/Global-Immunization- Data.pdf. Last accessed: October 2012.
6. World Health Organization, Regional Office for Europe. Available at: http://www.euro.who.int/mediacentre/PR/2008/20080421-1. Last accessed: 3 April 2010.
7. Law 27 May 1991, n. 165. Obbligatorietà della vaccinazione contro l'epatite virale B. Gazz. Uff. 1° giugno 1991, n. 127.
8. Zanetti AR, Tanzi E, Romanò L, Grappasonni I. Vaccination against hepatitis B: the Italian strategy. Vaccine 1993; 11:521-4; PMID:8488702; http://dx.doi.org/10.1016/0264-410X(93)90222-J. (Pubitemid 23130856)
9. Bonanni P. Implementation in Italy of a universal vaccination programme against hepatitis B. Vaccine 1995; 13(Suppl 1):S68-71; PMID:7571837.
10. Bonanni P, Pesavento G, Bechini A, Tiscione E, Mannelli F, Benucci C, et al. Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. Vaccine 2003; 21:685-91; PMID:12531340; http://dx.doi.org/10.1016/S0264-410X(02)00580-7. (Pubitemid 36091979)
11. The Italian Vaccine Coverage Survey Working Group. Childhood vaccination coverage in Italy: results of a seven-region survey. Bull World Health Organ 1994; 72:885-95; PMID:7867134.
12. Salmaso S, Rota MC, Ciofi Degli Atti ML, Tozzi AE, Kreidl P; ICONA Study Group. Infant immunization coverage in Italy: estimates by simultaneous EPI cluster surveys of regions. Bull World Health Organ 1999; 77:843-51; PMID:10593033.
13. Ministry of Health. Italy. Infection disease and Vaccination. Vaccination coverage. Ministry of Health website. Available at: http://www.salute.gov.it/ malattieInfettive/paginaInternaMenuMalattieInfettive.jsp?id =811&menu= strumentieservizi. Last accessed: October 2012.
14. Epicentro, Istituto Superiore di Sanità. Aspetti epidemiologici in Italia. 2011. Available at: http//www. epicentro.iss.it/problem/epatite/ EpidemiologiaItalia. asp. Last accessed: October 2012.
15. SEIEVA. (Sistema epidemiologico integrato dell'epatite virale acuta). Istituto Superiore di Sanità. SEIEVA website: www.iss.it/seieva/docu/ cont. Last accessed: October 2012.
16. Romano' L, Paladini S, Van Damme P, Zanetti AR. The worldwide impact of vaccination on the control and protection of viral hepatitis B. Dig Liver Dis 2011; 43(Suppl 1):S2-7; PMID:21195368; http://dx.doi.org/10.1016/S1590-8658(10) 60685-8.
17. Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 2008; 26:6266-73; PMID:18848855; http://dx.doi.org/10.1016/j.vaccine.2008.09.056.
18. Da Villa G, Romanò L, Sepe A, Iorio R, Paribello N, Zappa A, et al. Impact of hepatitis B vaccination in a highly endemic area of south Italy and longterm duration of anti-HBs antibody in two cohorts of vaccinated individuals. Vaccine 2007; 25:3133-6; PMID:17280750; http://dx.doi.org/10.1016/ j.vaccine. 2007.01.044. (Pubitemid 46482751)
19. Ministry of Health. Italy. Infection disease and Vaccination. Epidemiological bulletin. Ministry of Health website. Available at: http://www.salute.gov.it/malattieInfettive/paginaInternaMenuMalattieInfettive. jsp?id=812&menu=strumentieservizi. Last accessed: October 2012.
20. Mele A, Tosti ME, Mariano A, Pizzuti R, Ferro A, Borrini B, et al.; National Surveillance System for Acute Viral Hepatitis (SEIEVA) Collaborating Group. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis 2008; 46:868-75; PMID:18269332; http://dx.doi.org/10.1086/528687. (Pubitemid 351417188)
21. Steiner M, Ramakrishnan G, Gartner B, Van Der Meeren O, Jacquet JM, Schuster V. Lasting immune memory against hepatitis B in children after primary immunization with 4 doses of DTPa-HBVIPV/Hib in the first and 2nd year of life. BMC Infect Dis 2010; 10:9; PMID:20078876; http://dx.doi.org/10.1186/1471-2334- 10-9.
22. Zinke M, Kappes R, Kindler K, Paulus-Koschik A, Goering U, Disselhoff J, et al. Immune memory to hepatitis B virus in 4-9-year old children vaccinated in infancy with four doses of hexavalent DTPa-HBV-IPV/Hib vaccine. Hum Vaccin 2009; 5:592-8; PMID:19535920.
23. Zanetti AR, Romanò L, Giambi C, Pavan A, Carnelli V, Baitelli G, et al.; study group. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study. Lancet Infect Dis 2010; 10:755-61; PMID:20884297; http://dx.doi.org/10.1016/S1473-3099(10)70195-X.
24. Romanò L, Zanetti AR. Booster hepatitis B vaccination not necessary for long-term protection in children immunised with hexavalent vaccines. J Prev Med Hyg 2011; 52:45-6; PMID:21842704.
25. .Giambi C, Bella A, Barale A, Montù D, Marchisio M, Oddone M, et al. A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines. BMC Infect Dis 2008; 8:100; PMID:18662386; http://dx.doi.org/10.1186/1471-2334-8-100.